Merkel cell cancer overview: Difference between revisions

Jump to navigation Jump to search
No edit summary
Line 3: Line 3:


==Overview==
==Overview==
'''[[Merkel cell]] cancer''', also called '''Merkel cell carcinoma''', '''trabecular cancer''', '''Apudoma of skin''', or '''Small cell neuroepithelial tumor of the skin''', is a rare and highly aggressive [[cancer]] where [[malignant]] cancer cells develop on or just beneath the [[skin]] and in [[hair follicles]]. This cancer is a type of [[neuroendocrine tumor]], like [[small cell lung cancer]].  Merkel cell carcinoma is the most serious form of [[skin cancer]]. Once it has metastasized to the lymph nodes, the 5-year survival rate for a patient is about 50 percent. A small tumor (less than 2 cm) that has not metastasized to the lymph nodes reported a 5-year survival rate of more than 90 percent; however, at the time of diagnosis of MCC the 5-year survival was 64 percent. Recurrence can occur in up to half of all patients. <ref>{{cite journal | author = Allen PJ, Browne WB, Jaques DP, et al. | title = Merkel cell carcinoma: Prognosis and treatment of patients from a single institution. | journal = Journal of Clinical Oncology | volume = 23 | issue = 10 | pages = 2300-2309 | year = 2005}}</ref>
'''[[Merkel cell]] cancer''' is a rare and highly aggressive [[cancer]] where [[malignant]] cancer cells develop on or just beneath the [[skin]] and in [[hair follicles]]. This cancer is a type of [[neuroendocrine tumor]], like [[small cell lung cancer]].  Merkel cell carcinoma is the most serious form of [[skin cancer]]. Once it has metastasized to the lymph nodes, the 5-year survival rate for a patient is about 50 percent. A small tumor (less than 2 cm) that has not metastasized to the lymph nodes reported a 5-year survival rate of more than 90 percent; however, at the time of diagnosis of MCC the 5-year survival was 64 percent. Recurrence can occur in up to half of all patients. <ref>{{cite journal | author = Allen PJ, Browne WB, Jaques DP, et al. | title = Merkel cell carcinoma: Prognosis and treatment of patients from a single institution. | journal = Journal of Clinical Oncology | volume = 23 | issue = 10 | pages = 2300-2309 | year = 2005}}</ref>


It occurs most often on the face, head, and neck. It usually appears as firm, painless, [[nodule]]s, or [[tumor]]s. These flesh-colored, red, or blue tumors vary in size from 5 mm (less than a quarter of an inch) to more than 5cm (2 inches). The tumor grows rapidly. About half of all Merkel cell cancers occur on the sun-exposed areas of the head and neck, while one-third begin on the legs, and 15% occur on the arms. The cancer may also begin on other parts of the body, such as the trunk.
It occurs most often on the face, head, and neck. It usually appears as firm, painless, [[nodule]]s, or [[tumor]]s. These flesh-colored, red, or blue tumors vary in size from 5 mm (less than a quarter of an inch) to more than 5cm (2 inches). The tumor grows rapidly. About half of all Merkel cell cancers occur on the sun-exposed areas of the head and neck, while one-third begin on the legs, and 15% occur on the arms. The cancer may also begin on other parts of the body, such as the trunk.

Revision as of 12:49, 14 September 2012

Merkel cell cancer Microchapters

Home

Patient Information

Overview

Historical Perspective

Classification

Pathophysiology

Causes

Differentiating Merkel Cell Cancer from other Diseases

Epidemiology and Demographics

Risk Factors

Screening

Natural History, Complications and Prognosis

Diagnosis

Staging

History and Symptoms

Physical Examination

Laboratory Findings

CT

Other Imaging Findings

Other Diagnostic Studies

Treatment

Medical Therapy

Surgery

Primary Prevention

Secondary Prevention

Cost-Effectiveness of Therapy

Future or Investigational Therapies

Case Studies

Case #1

Merkel cell cancer overview On the Web

Most recent articles

Most cited articles

Review articles

CME Programs

Powerpoint slides

Images

American Roentgen Ray Society Images of Merkel cell cancer overview

All Images
X-rays
Echo and Ultrasound
CT Images
MRI

Ongoing Trials at Clinical Trials.gov

US National Guidelines Clearinghouse

NICE Guidance

FDA on Merkel cell cancer overview

CDC on Merkel cell cancer overview

Merkel cell cancer overview in the news

Blogs on Merkel cell cancer overview

Directions to Hospitals Treating Merkel cell cancer

Risk calculators and risk factors for Merkel cell cancer overview

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]

Overview

Merkel cell cancer is a rare and highly aggressive cancer where malignant cancer cells develop on or just beneath the skin and in hair follicles. This cancer is a type of neuroendocrine tumor, like small cell lung cancer. Merkel cell carcinoma is the most serious form of skin cancer. Once it has metastasized to the lymph nodes, the 5-year survival rate for a patient is about 50 percent. A small tumor (less than 2 cm) that has not metastasized to the lymph nodes reported a 5-year survival rate of more than 90 percent; however, at the time of diagnosis of MCC the 5-year survival was 64 percent. Recurrence can occur in up to half of all patients. [1]

It occurs most often on the face, head, and neck. It usually appears as firm, painless, nodules, or tumors. These flesh-colored, red, or blue tumors vary in size from 5 mm (less than a quarter of an inch) to more than 5cm (2 inches). The tumor grows rapidly. About half of all Merkel cell cancers occur on the sun-exposed areas of the head and neck, while one-third begin on the legs, and 15% occur on the arms. The cancer may also begin on other parts of the body, such as the trunk.

From initial onset, Merkel cell cancer metastasizes quickly and spreads to other parts of the body, tending towards the regional lymph nodes. The tumor tends to invade underlying subcutaneous fat, fascia, and muscle. It can also metastasize to the liver, lungs, brain or bones.

References

  1. Allen PJ, Browne WB, Jaques DP; et al. (2005). "Merkel cell carcinoma: Prognosis and treatment of patients from a single institution". Journal of Clinical Oncology. 23 (10): 2300–2309.


Template:WikiDoc Sources